Using cryoanalgesia to manage pain from rib fractures
Rib Fracture Cryoanalgesia
This study is testing if a new cold therapy can help people with rib fractures manage their pain better than regular pain medications.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 10 (estimated) |
| Ages | 18 Years to 75 Years |
| Sex | All |
| Sponsor | Methodist Health System Academic / other |
| Locations | 1 site (Dallas, Texas) |
| Trial ID | NCT06093776 on ClinicalTrials.gov |
What this trial studies
This observational study focuses on the use of cryoanalgesia as a pain management technique for patients with rib fractures. Conducted at Methodist Dallas Medical Center, the study aims to evaluate the effectiveness of the FDA-approved iovera system in providing pain relief. By analyzing a small cohort of patients, the research will refine the procedure and assess its preliminary efficacy. The goal is to improve patient outcomes and reduce reliance on traditional pain management methods, which often come with risks of opioid dependence.
Who should consider this trial
Good fit: Ideal candidates for this study are adults aged 18 and older with acute pain due to rib fractures.
Not a fit: Patients under 18, pregnant individuals, or those with specific medical conditions related to cold exposure may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could significantly improve pain management for rib fracture patients, leading to better recovery outcomes.
How similar studies have performed: While the use of cryoanalgesia is gaining attention, this specific application for rib fractures is relatively novel and has not been extensively tested in prior studies.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * 18 years of age Acute pain attributed to rib fracture(s) Able to obtain consent Exclusion Criteria: * \<18 years of age Pregnant Incarcerated Confounding injuries or significant pain attributed to secondary injury Patients with any of the following: cryoglobulinemia; paroxysmal cold hemoglobinuria; cold urticarial; Raynaud's disease; open and/or infected wounds at or near the treatment site
Where this trial is running
Dallas, Texas
- Methodist Dallas Medical Center — Dallas, Texas, United States (Recruiting)
Study contacts
- Study coordinator: Bethany Brauer, MPH
- Email: MHSIRB@mhd.com
- Phone: 214 947-4459
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.